---
figid: PMC3100630__cbt1109_0777_fig001
figtitle: EGFR biology
organisms:
- Homo sapiens
pmcid: PMC3100630
filename: cbt1109_0777_fig001.jpg
figlink: /pmc/articles/PMC3100630/figure/F1/
number: F1
caption: EGFR biology. Ligand binding to domains I and III of the EGFR expose the
  dimerization loop in domain II and induce receptor homo- or hetero-dimerization.
  This process activates the intrinsic tyrosine kinase activity of the EGFR and leads
  to the phosphorylation of specific tyrosines on the cytoplasmic tails of the receptor
  pair. These phospho-tyrosines serve to recruit specific effector molecules containing
  SH2 or PTB domains. These effector molecules recruit and induce various signaling
  pathways including the PI3K/AKT (A), RAS/MAPK (A), PLCγ/PKC (B) and STAT (B) pathways.
  In addition, a less appreciated pathway, the nuclear EGFR signaling pathway (C),
  is initiated upon ligand binding and induces EGFR translocation to the nucleus where
  it behaves as a co-transcriptional activator regulating key genes such as Cox2,
  iNOS, B-myb, Aurora kinase A and Cyclin D1.
papertitle: Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab.
reftext: Toni M Brand, et al. Cancer Biol Ther. 2011 May 1;11(9):777-792.
year: '2011'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.964849
figid_alias: PMC3100630__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC3100630__F1
ndex: 2e619013-dec9-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3100630__cbt1109_0777_fig001.html
  '@type': Dataset
  description: EGFR biology. Ligand binding to domains I and III of the EGFR expose
    the dimerization loop in domain II and induce receptor homo- or hetero-dimerization.
    This process activates the intrinsic tyrosine kinase activity of the EGFR and
    leads to the phosphorylation of specific tyrosines on the cytoplasmic tails of
    the receptor pair. These phospho-tyrosines serve to recruit specific effector
    molecules containing SH2 or PTB domains. These effector molecules recruit and
    induce various signaling pathways including the PI3K/AKT (A), RAS/MAPK (A), PLCγ/PKC
    (B) and STAT (B) pathways. In addition, a less appreciated pathway, the nuclear
    EGFR signaling pathway (C), is initiated upon ligand binding and induces EGFR
    translocation to the nucleus where it behaves as a co-transcriptional activator
    regulating key genes such as Cox2, iNOS, B-myb, Aurora kinase A and Cyclin D1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EGFR
  - MTG1
  - XYLT2
  - SOS1
  - SOS2
  - GRB2
  - KRAS
  - HRAS
  - NRAS
  - TSC2
  - HADH
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - BCL2L11
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - TF
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - PLCG1
  - PLCG2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - COX2
  - PTGS2
  - MTCO2P12
  - NOS2
  - ISYNA1
  - MYBL2
  - BAMBI
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
